U.S. flag An official website of the United States government
  1. Home
  2. Drug Databases
  3. Orange Book Home

Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations

Home | Back to Search Results

Product Details for ANDA 090212

Expand all

ADENOSINE (ADENOSINE)
60MG/20ML (3MG/ML)
Marketing Status: Prescription
Active Ingredient: ADENOSINE
Proprietary Name: ADENOSINE
Dosage Form; Route of Administration: SOLUTION; INTRAVENOUS
Strength: 60MG/20ML (3MG/ML)
Reference Listed Drug: No
Reference Standard: No
TE Code: AP
Application Number: A090212
Product Number: 001
Approval Date: Mar 28, 2014
Applicant Holder Full Name: MYLAN ASI LLC
Marketing Status:  Prescription
Patent and Exclusivity Information
ADENOSINE (ADENOSINE)
90MG/30ML (3MG/ML)
Marketing Status: Prescription
Active Ingredient: ADENOSINE
Proprietary Name: ADENOSINE
Dosage Form; Route of Administration: SOLUTION; INTRAVENOUS
Strength: 90MG/30ML (3MG/ML)
Reference Listed Drug: No
Reference Standard: No
TE Code: AP
Application Number: A090212
Product Number: 002
Approval Date: Mar 28, 2014
Applicant Holder Full Name: MYLAN ASI LLC
Marketing Status:  Prescription
Patent and Exclusivity Information
Back to Top